Chemoinformaics analysis of Tripropylsilyloxycyclobutane
| Molecular Weight | 228.452 | nRot | 8 |
| Heavy Atom Molecular Weight | 200.228 | nRig | 4 |
| Exact Molecular Weight | 228.191 | nRing | 1 |
| Solubility: LogS | -3.448 | nHRing | 0 |
| Solubility: LogP | 3.804 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 46.7122 |
| nHD | 0 | BPOL | 45.2658 |
| QED | 0.546 |
| Synth | 3.04 |
| Natural Product Likeliness | 0.155 |
| NR-PPAR-gamma | 0.152 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.023 |
| Pgp-sub | 0.989 |
| HIA | 0.002 |
| CACO-2 | -4.526 |
| MDCK | 0.000049 |
| BBB | 0.036 |
| PPB | 0.987458 |
| VDSS | 1.797 |
| FU | 0.01321 |
| CYP1A2-inh | 0.386 |
| CYP1A2-sub | 0.871 |
| CYP2c19-inh | 0.157 |
| CYP2c19-sub | 0.864 |
| CYP2c9-inh | 0.328 |
| CYP2c9-sub | 0.515 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.087 |
| CYP3a4-inh | 0.023 |
| CYP3a4-sub | 0.025 |
| CL | 7.244 |
| T12 | 0.21 |
| hERG | 0.023 |
| Ames | 0.003 |
| ROA | 0.001 |
| SkinSen | 0.638 |
| Carcinogencity | 0.34 |
| EI | 0.966 |
| Respiratory | 0.865 |
| NR-Aromatase | 0.555 |
| Antiviral | Yes |
| Prediction | 0.788589 |